Earnings History Data for Monte Rosa Therapeutics (GLUE) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Monte Rosa Therapeutics
Monte Rosa Therapeutics Inc. is a biotechnology company. It involved in developing a portfolio of novel small molecule precision medicines which employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. Monte Rosa Therapeutics Inc. is based in BOSTON.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | GLUE | Monte Rosa Therapeutics | 574.00 | -0.29 | -0.45 | 0.00 | Monte Rosa Therapeutics GAAP EPS of -$0.29 [11/7/2024 11:27 AM] |
9.57 | 0.12 (1.32%) |
9.54 | 0.09 (0.95%) |
2.91 - 12.40 | 1,003,055 | 11,120,000 | 10,211 | ||
|
||||||||||||||||||
| 08-08-2024 | PM | GLUE | Monte Rosa Therapeutics, Inc. | 197.00 | -0.43 | -0.50 | -0.71 | Monte Rosa Therapeutics GAAP EPS of -$0.43, revenue of $4.7M [8/9/2024 9:15 AM] |
3.90 | -0.08 (-2.01%) |
3.99 | 0.01 (0.25%) |
2.44 - 8.84 | 77,787 | 190,000 | 2,022 | ||
| 14-03-2024 | PM | GLUE | Monte Rosa Therapeutics | 304.00 | -0.58 | -0.57 | 0.00 | Monte Rosa Therapeutics GAAP EPS of -$0.58 [3/14/2024 11:48 AM] |
6.12 | -0.53 (-7.92%) |
6.45 | -0.20 (-3.01%) |
2.44 - 8.83 | 125,023 | 110,000 | 243 | ||
| 16-03-2023 | PM | GLUE | Monte Rosa Therapeutics | 306.00 | -0.63 | -0.64 | 0.00 | 6.97 | 0.44 (6.81%) |
0.0 | 0.0 (0.00%) |
5.74 - 15.52 | 88,148 | 110,000 | 0 | |||
|
|
||||||||||||||||||
| 10-11-2022 | PM | 7:30 AM ET (Nov 10) |
GLUE | Monte Rosa Therapeutics, Inc. | 385.86 | -0.58 | -0.61 | -0.43 | Monte Rosa Therapeutics GAAP EPS of -$0.58 beats by $0.02 [11/10/2022 9:27 AM] |
7.97 | 0.38 (4.93%) |
7.60 | 0.0 (0.00%) |
6.05 - 26.50 | 119,603 | 210,000 | 1,853 | |
| 11-05-2022 | PM | GLUE | Monte Rosa Therapeutics | 462.00 | -0.51 | -0.53 | 0.00 | Monte Rosa Therapeutics GAAP EPS of -$0.51 beats by $0.03 [5/11/2022 8:00 AM] |
7.96 | -1.46 (-15.50%) |
0.0 | 0.0 (0.00%) |
7.83 - 45.56 | 185,794 | 130,000 | 0 | ||
| 29-03-2022 | ?? | 7:30 AM ET (Mar 29) |
GLUE | Monte Rosa Therapeutics, Inc. | 506.91 | N/A | -0.51 | 0.00 | Monte Rosa Therapeutics GAAP EPS of -$2.96 misses by $0.43 [3/29/2022 8:09 AM] |
13.54 | 0.86 (6.78%) |
12.68 | 0.0 (0.00%) |
9.82 - 45.56 | 197,006 | 650,000 | 9,028 | |
| 10-11-2021 | PM | 7:30 AM ET (Nov 10) |
GLUE | Monte Rosa Therapeutics | 1,121 | -0.43 | -0.46 | 0.00 | Monte Rosa Therapeutics EPS beats by $0.03 [11/10/2021 9:12 AM] |
22.98 | 1.07 (4.88%) |
21.91 | 0.0 (0.00%) |
17.39 - 45.56 | 39,605 | 90,000 | 388 | |